CJC-1295 + Ipamorelin China Wholesale Guide

Name both components and the CJC-1295 form

A wholesale blend specification must identify CJC-1295 without DAC, also described in some contexts as modified GRF 1-29, separately from Ipamorelin. The phrase CJC-1295 is sometimes used ambiguously, so require the supplier to confirm the exact molecular definition. State the nominal amount of each component and the total per vial. Do not let a shorthand such as “CJC/IPA 10mg” replace a controlled specification because the same total could represent different component ratios.

Lock the ratio and quantity basis

For a 5mg + 5mg presentation, confirm that each component has a nominal 5mg content and that 10mg refers to the combined total. Ask how component quantities are established and what tolerance applies. If another ratio is offered, quote it as a separate SKU rather than a substitution. Compare total vials, total amount of each component and price per finished configuration. HPLC peak area should not be treated as a direct measurement of the milligrams of each peptide without an appropriate quantitative method.

Review component identity and blend evidence

A two-component material creates additional analytical questions. Ask how the supplier supports the identity of both CJC-1295 without DAC and Ipamorelin and how chromatographic purity is interpreted for the mixture. Mass spectrometry evidence should account for each expected component when it is part of the release package. Check that analytical files identify the blend lot and are not unrelated single-component examples. The buyer's specification should state which results are required for each component and for the finished blend.

Understand blending and filling traceability

Request the relationship among source-material lots, the blend or compounding record and the finished vial lot. Confirm how quantities are reconciled and how mix-ups between component powders or similar vial strengths are controlled. If the supplier purchases one component from a partner, that role should be disclosed and records preserved. Finished labels and the COA should identify both components, their nominal amounts and the batch reference. A single generic blend code without a controlled key creates avoidable receiving risk.

Compare premixed blend and separate-vial quotations

A premixed vial can simplify finished-unit inventory, while separate component vials preserve independent lot and quantity control. Compare the two formats according to the approved research workflow; this article does not provide preparation or human-use instructions. The quotation should distinguish material, testing, filling, components, packaging and freight. If the laboratory requests separate vials, require separate COAs and lot identifiers. If it requests a blend, require documentation for both input identity and finished configuration.

Build a China wholesale release checklist

Before dispatch, reconcile the product definition, 5mg + 5mg ratio, total vial count, batch identifiers, COA, analytical attachments, label proof, SDS and shipping documents. Verify that the offered stock quantity comes from the documented lot and that repeat orders will not silently change the CJC-1295 form or ratio. At receipt, inspect labels, count units and quarantine discrepancies. A controlled first order and risk-based confirmatory testing can support qualification before larger or recurring procurement.

Quality Control: connect every claim to evidence

Define required tests and acceptance criteria before requesting a final quotation. HPLC commonly supports chromatographic purity, and mass spectrometry can support molecular identity, but neither should be used to imply untested attributes. Check the sample identifier, test date, report number, units and lot relationship. Review the Pure Peptides Core quality-control framework and require clarification when a marketing statement extends beyond the underlying method. For wholesale release, batch-specific evidence is more useful than a representative certificate.

Documentation: approve the lot before shipment

List the required files in the RFQ and purchase order. The set may include a batch COA, analytical attachments, SDS, specification, label proof, supported storage statement, packing list and commercial shipment records. Reconcile product name, strength, quantity and lot across documents. Use the documentation support guide as a review framework. The importer or its broker remains responsible for current destination rules, and research-use documentation does not guarantee customs entry.

Related products and reading

Review relevant catalog presentations and continue with same-category procurement resources:

• CJC-1295 + Ipamorelin 10mg Blend
• Regenerative and Growth Peptide Sourcing Guide
• Peptide Lot Traceability Checklist

Frequently asked questions